Compounds > lysophosphatidic acid
Page last updated: 2024-08-26

lysophosphatidic acid and Retinal Diseases

lysophosphatidic acid has been researched along with Retinal Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, P; Connell, PP; Conquest, A; Daniszewski, M; Guymer, RH; Hernández, D; Hewitt, AW; Liang, HH; Lidgerwood, GE; Lim, SY; Morris, AJ; Pébay, A; Rooney, LA1
Dhallu, MS; Malhotra, S; Mammis, A; Ocava, LC; Rosenbaum, DM; Rosenbaum, PS; Savitz, SI1
Hata, Y; Ishibashi, T; Kano, K; Kita, T; Miura, M; Nakao, S; Noda, Y; Shimokawa, H1

Other Studies

3 other study(ies) available for lysophosphatidic acid and Retinal Diseases

ArticleYear
Role of lysophosphatidic acid in the retinal pigment epithelium and photoreceptors.
    Biochimica et biophysica acta. Molecular and cell biology of lipids, 2018, Volume: 1863, Issue:7

    Topics: Blood-Retinal Barrier; Cell Line; Cytoskeleton; Humans; Lysophospholipids; Phagocytosis; Phosphoric Diester Hydrolases; Photoreceptor Cells, Vertebrate; Pluripotent Stem Cells; Retinal Diseases; Retinal Pigment Epithelium; Tight Junctions; Vitrectomy

2018
EDG receptors as a potential therapeutic target in retinal ischemia-reperfusion injury.
    Brain research, 2006, Nov-06, Volume: 1118, Issue:1

    Topics: Animals; Apoptosis; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Intraocular Pressure; Lysophospholipids; Male; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid; Receptors, Lysosphingolipid; Reperfusion Injury; Retinal Diseases; Signal Transduction; Treatment Outcome

2006
Transforming growth factor-beta2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor.
    Diabetes, 2007, Volume: 56, Issue:1

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Connective Tissue Growth Factor; Gene Expression Regulation; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Intracellular Signaling Peptides and Proteins; Lysophospholipids; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Recombinant Proteins; Retinal Diseases; rho-Associated Kinases; RNA, Messenger; Transforming Growth Factor beta2; Vitrectomy; Vitreous Body

2007